Skip to content
Colorectal Cancer Clinical Trials

Participant guide

Informed consent explained

Informed consent is how you learn what a colorectal cancer study involves before you decide whether to take part. Think of it as a conversation with the study team. The signature is only one piece of it.

Updated

What you are told

Nothing gets signed first. The team running the colorectal cancer study talks you through it, then hands you the consent document in writing so you can read it for yourself before you decide. Expect it to spell out:

  • the reason for the study and its length;
  • your part in it, meaning the tasks, the tests and the visits;
  • known discomforts and risks;
  • what benefits, if any, could reasonably be expected;
  • alternatives available to you apart from the study;
  • the way your information is kept confidential;
  • the person to reach when a concern or a question comes up.

Take your time

The document can go home with you. Go through it with family or your own doctor, and keep asking questions until you have what you need. This list of questions worth asking is a good place to start.

Consent is ongoing

No, your signature does not lock you in. The consent document is no contract. Leaving the study stays your choice at any time. And when something new is learned partway through that could change how you feel about taking part, the team must share it with you.

Talk with a study coordinator

Phone (888) 385-9581, or submit the short form if you prefer. Either way, a coordinator tells you which colorectal cancer studies could be a fit and lays out what happens next. You can ask as much as you like without being tied to anything.

Call (888) 385-9581

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call